secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adhera Therapeutics, Inc. (—)
CIK:        0000737207
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001493152-24-002422
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Adhera Therapeutics CEO and director resign, effective Jan 12, 2024
-------------------------------------------------------------------

- Trond K. Waerness resigns from Board effective January 12, 2024; no disagreement cited.
- Zahed Subhan resigns as CEO and Board member effective January 12, 2024; no disagreement cited.
- Both departures are not related to company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer